TuHURA Biosciences, Inc. HURA Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0×— | 0×— | 0×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 1.2×-1.8× | 0.8×-2.9× | 0.4×-1.1× | 0.8×— | 3×— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | 0×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.39+70.1% | $0.44-44.1% | $0.33+246% | $0.44— | $0.23— | |
| Valuation | ||||||
| Market capitalization | $155.39M+45.8% | $42.74M— | $126.74M— | —— | —— | |
| Price / book | 6.7×+1.2× | 2×— | 7.6×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do TuHURA Biosciences, Inc.'s ratios come from?
- Every ratio is computed from TuHURA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.